By Ross Bonander, Tue, August 12, 2014 The US Food and Drug Administration yesterday approved Cologuard, the first stool-based colorectal screening test that detects the presence of red blood cells and DNA mutations that might indicate the presence of certain kinds of abnormal growths that may be cancers such as colon cancer or precursors to cancer.